Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial

Emary, Katherine RW; Golubchik, Tanya; Aley, Parvinder K; Ariani, Cristina V; Angus, Brian; Bibi, Sagida; Blane, Beth; Bonsall, David; Cicconi, Paola; Charlton, Sue; +54 more... Clutterbuck, Elizabeth A; Collins, Andrea M; Cox, Tony; Darton, Thomas C; Dold, Christina; Douglas, Alexander D; Duncan, Christopher JA; Ewer, Katie J; Flaxman, Amy L; Faust, Saul N; Ferreira, Daniela M; Feng, Shuo; Finn, Adam; Folegatti, Pedro M; Fuskova, Michelle; Galiza, Eva; Goodman, Anna L; Green, Catherine M; Green, Christopher A; Greenland, Melanie; Hallis, Bassam; Heath, Paul T; Hay, Jodie; Hill, Helen C; Jenkin, Daniel; Kerridge, Simon; Lazarus, Rajeka; Libri, Vincenzo; Lillie, Patrick J; Ludden, Catherine; Marchevsky, Natalie G; Minassian, Angela M; McGregor, Alastair C; Mujadidi, Yama F; Phillips, Daniel J; Plested, Emma; Pollock, Katrina M; Robinson, Hannah; Smith, Andrew; Song, Rinn; Snape, Matthew D; Sutherland, Rebecca K; Thomson, Emma C; Toshner, Mark; Turner, David PJ; Vekemans, Johan; Villafana, Tonya L; Williams, Christopher J; Hill, Adrian VS; Lambe, Teresa; Gilbert, Sarah C; Voysey, Merryn; Ramasamy, Maheshi N; Pollard, Andrew J; COVID-19 Genomics UK consortium, AMPHEUS Project, Oxford COVID-19 Vaccine Trial Group; (2021) Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial. Lancet (London, England), 397 (10282). pp. 1351-1362. ISSN 0140-6736 DOI: https://doi.org/10.1016/s0140-6736(21)00628-0

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/s0140-6736(21)00628-0

Abstract

Share

Download

Filename: 1-s2.0-S0140673621006280-main.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar